Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
CTAD
GLP-1 Semaglutide Fails to Slow Alzheimer’s Despite Biomarker Changes
POINTER: Lifestyle Shifts Improve Sleep and Brain Blood Vessels
A Round-up of Alzheimer’s Drug Trials News From CTAD 2024
Dispatch from CTAD 2024
CTAD: Leqembi’s Origin Story, 30 Years Ago in Arctic Sweden
CTAD: Updating the Definition—and Diagnostic Criteria—of Alzheimer’s
CTAD: Multiple Alzheimer’s Vaccines Show Promise in Early Trials
CTAD: T3D’s Experimental Alzheimer’s Pill Is Insulin for the Brain
Deborah Kan: Dispatch from CTAD 2022
CTAD: Day One Round-up—Biogen, Blood Pressure Control
Page load link
Go to Top